Noom operates multiple subscription tiers that can be billed separately — the biggest mistake when leaving is cancelling only one of them and assuming you're fully off the hook.
If you're moving to a new provider, Luma Health's semaglutide ($197/month) and tirzepatide ($297/month) include a medical evaluation to plan your transition.
Cancelling Noom Med cleanly requires understanding that "Noom" isn't necessarily one subscription — it can be several. Here's a checklist to make sure you actually stop all the billing you intend to.
Step 1: Identify Every Active Subscription
Check whether you have a separate Noom Weight (behavioral coaching app) subscription in addition to your Noom Med (medication) program — these can be billed independently, and cancelling one doesn't automatically cancel the other. Log into your account and review your active subscriptions individually before starting the cancellation process.
Step 2: Decide What You're Actually Cancelling
If you're switching medication providers but want to keep using Noom's coaching app, cancel only the medication program and confirm the app subscription remains active and separately billed. If you want to leave entirely, you'll need to cancel both subscriptions individually.
Start your new provider's medical evaluation while you still have some current medication remaining, so your new prescription is approved and shipping before your Noom supply runs out. Share your current dose, duration on treatment, and any side effects with your new provider to avoid unnecessary retitration.
Step 3: Cancel Through the App
Cancellation is typically done within the Noom app under account or subscription settings. If self-service cancellation isn't available for your specific plan, contact Noom support directly and explicitly specify which subscription (medication program vs. coaching app) you're cancelling, to avoid ambiguity.
Step 4: Confirm and Monitor
Save your cancellation confirmation (email or in-app screenshot). Check your bank or card statement for two to three billing cycles afterward to make sure charges have actually stopped, and dispute any unauthorized charges with your bank or app store if they continue.
Your Exit Checklist
- Confirm which specific subscriptions you have active
- Start your new provider's intake if you're switching, not stopping
- Note your current dose and treatment history to share
- Save written confirmation of the cancellation
- Check statements for 2-3 billing cycles to confirm charges stopped
- Dispute any charges that continue despite confirmed cancellation
Ready for a
simpler, flat price?
Luma Health's compounded semaglutide ($197/month) and tirzepatide ($297/month) include your medical evaluation and ongoing provider access — no app subscription required.
Get Started → Or start your free health assessmentFrequently Asked Questions
Not necessarily — these can be separate subscriptions billed independently. Check your account for both before assuming one cancellation covers everything.
Start your new provider's medical evaluation while you still have some current medication remaining, so your new prescription is approved and shipping before your supply runs out.
Yes, in many cases — cancel just the medication program and confirm your app subscription (if separate) remains active if you want to keep using it.
Contact Noom support directly and explicitly specify which subscription you want cancelled to avoid confusion between the medication program and the coaching app.
Save your cancellation confirmation and check your bank or card statement for two to three billing cycles afterward to verify no further charges appear.
Your current medication and dose, how long you've been taking it, and any side effects — this lets a new provider continue your treatment plan without unnecessary retitration.
References
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PubMed 35441470
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov. 2025. FDA Drug Approvals Database